Nu Holdings' Growth Story Meets 2026 Inflection Risks

What happened

Nu Holdings is reporting strong metrics with 45% FX-neutral revenue growth and 33% ROE, as highlighted in a recent Seeking Alpha article that touts its LatAm expansion potential. However, the DeepValue report reveals management's guidance for a 2026 investment ramp in AI and new markets, which will likely push the efficiency ratio higher and pressure near-term margins. Critical regulatory overhangs persist, including Mexico's proposed interchange caps that could slash card fees by up to 55% and ongoing complexities in U.S. charter approval. The article's optimistic framing downplays these execution risks and the need for offsetting operational leverage to sustain profitability. Investors must now watch for proof points in efficiency ratios, ARPAC trends, and regulatory outcomes over the next 2-3 quarters to validate the growth trajectory.

Implication

Nu's impressive growth metrics are tempered by a deliberate 2026 cost increase that challenges near-term profitability and requires careful monitoring. The Mexico interchange cap proposal poses a tangible threat to revenue, with potential cuts of 44-55% if finalized, directly impacting card economics. U.S. expansion adds compliance complexity and execution risk, potentially diverting resources without immediate returns. Key indicators to watch include the efficiency ratio staying below 23%, ARPAC growth of at least 10% YoY, and stable NPL ratios near 4.1%. Until these factors show resilience against the investment ramp and regulatory headwinds, the WAIT rating remains prudent to avoid valuation disappointment.

Thesis delta

The Seeking Alpha article reinforces Nu's growth narrative but does not alter the core thesis from the DeepValue report, which already prices in high profitability amid rising risks. The shift remains minimal: the thesis still hinges on Nu navigating the 2026 cost ramp and Mexico regulatory overhang without credit deterioration, with no new catalysts from the article. Investors must continue to await observable proof in efficiency and regulatory milestones before upgrading from the WAIT stance.